Rykindo® (risperidone) – New drug approval l
January 15, 2023 - Luye Pharma announced the FDA approval of Rykindo (risperidone) extended-release injectable suspension, for the treatment of schizophrenia in adults and as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder in adults.
Top